European Commission secures EU access to Remdesivir for treatment of COVID-19

coronavirus 2021

(Credit: Unsplash)

This article is brought to you in association with the European Commission.


Yesterday, the European Commission has signed a contract with the pharmaceutical company Gilead to secure treatment doses of Veklury, the brand name for Remdesivir. Veklury was the first medicine authorised at EU level for treatment of COVID-19. As from early August onwards, and in order to meet immediate needs, batches of Veklury will be made available to Member States and the UK, with the coordination and support of the Commission.

Stella Kyriakides, Commissioner for Health and Food Safety, said: “In recent weeks, the Commission has been working tirelessly with Gilead to reach an agreement to ensure that stocks of the first treatment authorised against COVID-19 are delivered to the EU. A contract has been signed yesterday, less than a month after the authorisation of Remdesivir, which will allow the delivery of treatments from early August for thousands of patients. The Commission is leaving no stone unturned in its efforts to secure access to safe and efficient treatments, and is supporting the development of vaccines against coronavirus. Yesterday’s agreement is another important step forward in our fight to overcome this disease”.

The Commission’s Emergency Support Instrument will finance the contract, worth a total of €63 million. This will ensure the treatment of approximately 30,000 patients presenting severe COVID-19 symptoms. This will help to cover the current needs over the next few months, while ensuring a fair distribution at EU level, based on an allocation key, taking into account the advice from the European Centre for Disease Prevention and Control.

The Commission is now also preparing a joint procurement for further supplies of the medicine, expected to cover additional needs and supplies as from October onwards.

Background

On 3 July, Remdesivir became the first treatment to be authorised for a conditional marketing authorisation. This authorisation facilitates early access to medicines in public health emergency situations, such as the current pandemic.

Remdesivir is a treatment against COVID-19 for adults and adolescents as from age 12 with pneumonia who require supplemental oxygen. The application for the marketing authorisation was submitted to the European Medicines Agency (EMA) on 8 June. EMA’s recommendation was endorsed by the Member States through the Standing Committee on Medicinal Products for Human Use.

While authorised in the EU, the medicine continues to be monitored to ensure safety. Gilead has also been requested to submit the final reports of the Remdesivir studies to the EMA by December 2020 as part of the conditions to be fulfilled to move from a conditional marketing authorisation to a full marketing authorisation. Further data on the effectiveness and safety of the medicine is expected to be submitted by August 2020 in order to finalise this process.

the sting Milestone

Featured Stings

How to build a more resilient and inclusive global system

Can we feed everyone without unleashing disaster? Read on

These campaigners want to give a quarter of the UK back to nature

Stopping antimicrobial resistance would cost just USD 2 per person a year

China is a renewable energy champion. But it’s time for a new approach

250+ senior claims leaders under one roof, exchanging transformation strategy

More needs to be done to bridge the digital gender divide

Parliament commemorates the liberation of Auschwitz 75 years ago

Upgraded EU visa information database to increase security at external borders

Khashoggi murder trials must public and meet international standards, UN expert urges

How LA plans to be 1.6°C cooler by 2050

Seize the opportunities of digital technology to improve well-being but also address the risks

Women’s work faces the greatest risk of automation, says new research

Is a deal over EU budget possible today?

‘Global sisterhood’ tells perpetrators ‘time is up’ for pandemic of violence

WEF Davos 2016 LIVE: “CO2 is not the problem, it is the symptom”, the pilots who crossed the world using solar energy cry out from Davos

“The Belt and Road Initiative should be mutually beneficial for EU and China and every participating country”, Vice-President Papadimoulis of the European Parliament underscores from European Business Summit 2018

Single Market Scoreboard 2020: Member States need to do more to ensure the good functioning of the EU Single Market*

This is what the UK’s major supermarkets say about plastic packaging and the environment

MEPs demand an end to migrant deaths across the Mediterranean Sea

Pakistan’s digital revolution is happening faster than you think

Syria still suffering ‘staggering levels’ of humanitarian need, Security Council hears

From low-earth orbit, ‘envoys’ of humanity join UN space forum

Find unity ‘to halt Libya’s senseless unraveling’, UN envoy urges Security Council

Burnout is a pandemic. Why don’t we talk more about it?

UN chief extends condolences to families of China landslide casualties

Quashing myths on 2019-nCoV for better public management

DR Congo Ebola centre attacks could force retreat against the deadly disease, warns UN health chief

EU-Ukraine Free Trade Agreement sees the light as Moscow’s reaction once more looms

How speaking ‘parentese’ to your child could make them a faster learner

Five-year low inflation for Eurozone and now Mario has to finally wake up the Germans

Idai disaster: Stranded victims still need rescue from heavy rains as UN scales up response

EU-China: Council authorises signature of the agreement on geographical indications

War in Syria: ‘Carnage’, flouting of rights and international law, must stop: Guterres

Youth Forum welcomes European Commission proposal to speed up financing for youth employment

MasterCard at European Business Summit 2015: A focus on innovation will drive inclusive economic growth for Europe

Is technology key to improving global health and education, or just an expensive distraction?

Rule of Law: European Commission refers Poland to the Court of Justice to protect judges from political control

What is behind the wide reach of  fake news about Coronavirus?

EU-Vietnam trade agreement enters into force

Why impoverishment and social exclusion grow in the EU; the affluent north also suffers

COVID-19 and nature are linked. So should be the recovery.

Corporate tax remains a key revenue source, despite falling rates worldwide

Residents and visitors to this Dutch neighborhood could share a pool of cars and bikes

Europe might not avoid new partitioning on Ukrainian crisis

Draghi to hold on zero interest rates until he leaves ECB

This is how drones and other ‘tradetech’ are transforming international trade

Empathy and human connection: how businesses can respond to COVID-19

UNICEF reports uneven progress in 30 years of child rights treaty

3 important lessons from 20 years of working with social entrepreneurs

United States: UN chief ‘deeply saddened’ by deadly California wildfires

Coronavirus: Commission Statement on consulting Member States on proposal to further expand State aid Temporary Framework to recapitalisation measures

Europe united in not supporting a US attack on Syria

These are the world’s 10 most competitive economies in 2019

Apple’s tax avoidance scheme remains as creative as their new iPhone

Practicing healthcare: Skills of a good healthcare professional and its effects

The European Sting live from the World Economic Forum 2015 in Davos

How global tech companies can champion ethical AI

Parliament wants to suspend EU accession negotiations with Turkey

‘Fire-fighting approach’ to humanitarian aid ‘not sustainable’: Deputy UN chief

This is the critical number that shows when housing breaks down

Horn of Africa: UN chief welcomes Djibouti agreement between Eritrea, Ethiopia and Somalia

Guterres appeals for ‘maximum restraint’ over Jammu and Kashmir, as tensions rise

More Stings?

Advertising

Speak your Mind Here

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s